Targeting the p38 MAPK Pathway Inhibits Irinotecan Resistance in Colon AdenocarcinomaSalomé Paillas, Céline Gongora|Cancer Research|2010Cited by 87
Targeting the NRG1/HER3 pathway in tumor cells and cancer-associated fibroblasts with an anti-neuregulin 1 antibody inhibits tumor growth in pre-clinical models of pancreatic cancerCharline Ogier, Christel Larbouret, Marta Jarlier et al.|Cancer Letters|2018Cited by 57
FOXO3a and the MAPK p38 are activated by cetuximab to induce cell death and inhibit cell proliferation and their expression predicts cetuximab efficacy in colorectal cancerLaetitia Marzi, Céline Gongora|British Journal of Cancer|2016Cited by 51
Inhibiting microtubule polymerization with EAPB02303, a prodrug activated by catechol-O-methyl transferase, enhances paclitaxel effect in pancreatic cancer modelsKévin Bigot, Christel Larbouret, Cindy Patinote et al.|Cell Death and Disease|2025Cited by 1